Literature DB >> 1495505

Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.

N Yuki1, H Yoshino, S Sato, K Shinozawa, T Miyatake.   

Abstract

We report cases of 2 patients with pure motor Guillain-Barré syndrome of explosive onset who required mechanical ventilation for more than 2 months. Their electrophysiologic findings and poor clinical recoveries suggested severe axonal degeneration involving the motor nerves. Enzyme-linked immunosorbent assay and thin-layer chromatogram-immunostaining showed the sera of both patients had high IgG antibody titer against GD1a ganglioside. Their titers decreased with the clinical course of the illness. GD1a as well as GM1, appears to be the target pathogenic antigen in motor axon disorders. Elevated IgG anti-GD1a antibody titer may prove useful for predicting severe GBS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495505     DOI: 10.1002/mus.880150806

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

Review 1.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.

Authors:  K Mizoguchi; A Hase; T Obi; H Matsuoka; M Takatsu; Y Nishimura; F Irie; Y Seyama; Y Hirabayashi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

Review 3.  Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

Authors:  H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

4.  On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy.

Authors:  Dirk Fischer; Christoph Grothe; Stephan Schmidt; Rolf Schröder
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

5.  Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis.

Authors:  K Sugita; M Ishii; J Takanashi; H Niimi; N Yuki
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

6.  Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.

Authors:  F J Vriesendorp; W J Triggs; R F Mayer; C L Koski
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

7.  The F wave disappears due to impaired excitability of motor neurons or proximal axons in inflammatory demyelinating neuropathies.

Authors:  T Yokota; A Inaba; N Yuki; T Ichikawa; H Tanaka; Y Saito; T Kanouchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.

Authors:  Kazim A Sheikh; Gang Zhang
Journal:  F1000 Biol Rep       Date:  2010-03-25

9.  Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome.

Authors:  A R Exley; N Smith; J B Winer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

10.  Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome.

Authors:  C Y Li; P Xue; W Q Tian; R C Liu; C Yang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.